Status:
RECRUITING
Is the BAT Inhibition Able to Replace Sting Challenges? (BATIRS)
Lead Sponsor:
Medical University of Graz
Conditions:
Vespid Venom Allergy
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Insect venom allergy is the major cause for severe allergic reactions in Europe. Wasps and honeybees are responsible for the majority of these allergic reactions. Symptoms range from generalized skin ...
Eligibility Criteria
Inclusion
- Legally competent male and female subjects who are currently treated or who have been treated with vespid venom immunotherapy
- Age ≥18 and ≤70 years
- Written consent of the participant after being informed
Exclusion
- Pregnancy
- Autoimmune disease
- Uncontrolled cardiovascular disease
- Uncontrolled asthma
Key Trial Info
Start Date :
January 7 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
219 Patients enrolled
Trial Details
Trial ID
NCT04438525
Start Date
January 7 2021
End Date
December 1 2026
Last Update
September 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Dermatology and Venerology, Medical University of Graz
Graz, Austria, 8036